Table 4 Subgroup analysis of the associations between MetS and urologic, kidney, prostate, and bladder cancer risk

Age(years)

  < 45

1.98 (0.96–4.08)

2.54 (1.07–6.06)

-

1.63 (0.39–6.91)

 45–54

1.48 (1.02–2.16)

1.82 (1.13–2.95)

1.61 (0.54–4.79)

0.87 (0.38–2.01)

 55–64

1.13 (0.83–1.55)

1.34 (0.77–2.32)

1.39 (0.81–2.41)

0.97 (0.54–1.73)

  ≥ 65

1.15 (0.85–1.56)

1.47 (0.67–3.23)

1.35 (0.84–2.18)

0.81 (0.50–1.32)

P_trend

 < 0.001

0.033

 < 0.001

 < 0.001

Gender

 Female

0.77 (0.34–1.77)

0.49 (0.16–1.56)

-

3.44 (0.60–19.65)

 Male

1.33 (1.10–1.60)

1.96 (1.42–2.71)

-

0.87 (0.62–1.22)

Occupation

 White collar

0.41 (0.19–0.91)

0.28 (0.06–1.29)

0.87 (0.25–2.99)

0.33 (0.07–1.58)

 Blue collar

1.40 (1.16–1.69)

1.98 (1.44–2.72)

1.54 (1.08–2.20)

0.98 (0.70–1.38)